Latest news
Schizophrenia Gets a Five-Day Brain-Stimulation Signal
A small sham-controlled trial found substantial short-term symptom improvement after fronto-temporal tDCS in treatment-resistant schizophrenia. The signal is striking. The evidence is still much too small to call it a treatment answer.
Age does not affect maternal cardiovascular risk equally. California data show widening Black-White gaps
10,000 steps is not the only route to lower cardiovascular risk. Walking pace may matter too
AI is moving inside the medical record. Privacy is only part of the risk
The mRNA Cancer Vaccine Story Just Got Less Comfortable
Thailand Beat Rubella.
Three drugs, three biological hypotheses: Kardigan is putting precision cardiology to the test
IPM Brief – Issue 29 | Science gained muscle. Power kept the grip.
RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.
Outbreaks Ignore Borders.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.